
Blood draw
Lupus anticoagulant
Tests for lupus anticoagulant, antibodies that increase the risk of thrombosis. For people who have had thrombosis or repeated miscarriages.
€ 78,00
Your privacy
Necessary cookies keep the website working.
With your consent, we use additional cookies to:
We may share visited pages, interactions and device data with 5 service providers.
Hashed contact details are shared only with marketing consent.
You can change this later through Cookie preferences at the bottom of every page.
More information is available in our privacy policy.
Other analyses · Blood
Antibodies that prolong clotting tests but increase the risk of thrombosis; part of testing for antiphospholipid syndrome.
At a glance
Lupus anticoagulant
Explanation
Despite the name, lupus anticoagulant is not an anticoagulant and is not found only in the disease lupus. These are autoantibodies: antibodies that the body makes by mistake against proteins that bind to phospholipids (fat-like building blocks of cells). In the tube they prolong clotting tests, but in the body they actually increase the risk of thrombosis. The laboratory measures them with the dRVVT (dilute Russell's viper venom time): a screening test and a confirmation test with extra phospholipids. If the screening time is prolonged and becomes shorter with extra phospholipids, lupus anticoagulant is present.
Result
A positive result means that lupus anticoagulant has been detected. That is not yet a diagnosis: according to the Dutch Society for Clinical Chemistry (NVKC) and the Dutch medical specialists' guideline (FMS), the test is repeated after at least 12 weeks, because lupus anticoagulant can also be present temporarily, for example during or after an infection. If the result is positive again and there has been a thrombosis or a pregnancy problem, such as repeated miscarriages, antiphospholipid syndrome may be present. Lupus anticoagulant is more common in people with the autoimmune disease lupus (SLE). According to the NVKC, a positive result without thrombosis and without pregnancy problems does not in principle lead to treatment.
A negative result means that no lupus anticoagulant was found with this test. That does not rule out antiphospholipid syndrome: the laboratory only uses the dRVVT, while international agreements also call for a second test based on the aPTT, and the syndrome can also show up as antibodies against cardiolipin or beta-2 glycoprotein I. With a thrombosis and a negative result, the cause is investigated further. According to the NVKC, in people with lupus (SLE) the test is repeated regularly.
With a positive result, the test is repeated after at least 12 weeks, together with antibodies against cardiolipin and beta-2 glycoprotein I. If the result stays positive and there has been a thrombosis or pregnancy problem, the GP refers to an internist. With confirmed antiphospholipid syndrome after a thrombosis, the FMS guideline usually advises a coumarin over a DOAC, and with repeated early miscarriages, treatment with low-dose aspirin and heparin can be considered in a next pregnancy.
Reliability
The result mainly says something in people with a thrombosis at a young age or without a clear cause, with repeated miscarriages or with an autoimmune disease such as lupus. According to the FMS guideline, a positive result only counts if it is positive again after at least 12 weeks. The measurement is easily disturbed: anticoagulants can give a false-positive or uninterpretable result, and platelets left in the plasma a false-negative one. In people without thrombosis or pregnancy problems, a positive result is hard to interpret.
Who it is for
Useful with a thrombosis at a young age, in an unusual place or without a clear trigger, with repeated miscarriages or other pregnancy problems, with an unexplained prolonged aPTT and with lupus (SLE). The FMS guideline recommends testing women with at least three miscarriages before 10 weeks of pregnancy for lupus anticoagulant, together with antibodies against cardiolipin and beta-2 glycoprotein I. With the use of anticoagulants, the result often cannot be reliably interpreted. In people without such events, the predictive value is low and no treatment follows.
According to the NVKC, an estimated 1 to 2 in 100 people make antibodies against phospholipids, but most have no problems from them. Antiphospholipid syndrome itself is rare. Lupus anticoagulant is more common in people with lupus (SLE) and temporarily after infections.
NVKC, allesovertesten.nl; no Dutch prevalence figure for APS checked
Get tested
Lupus anticoagulant is part of these test panels. You order online and have your blood drawn at a collection point or collect the sample at home.
Evidence
This explanation is based on Dutch guidelines and independent information. It is general information, not a diagnosis. Discuss an abnormal result with your GP.
More about risks and resultsMore explanations